Role of Catheter Ablation as a First-Line Treatment for Atrial Fibrillation

Purpose of review Catheter ablation has emerged as the most effective long-term rhythm controlling strategy in patients with symptomatic atrial fibrillation (AF). Over the last few years, the role of ablation has shifted from a last-resort strategy toward a first-line approach in AF management. The...

Full description

Saved in:
Bibliographic Details
Published in:Current treatment options in cardiovascular medicine 2020-11, Vol.22 (11), p.38, Article 38
Main Authors: El Masri, Ibrahim, Kayali, Sharif M, Manolukas, Theodore, Levine, Yehoshua C.
Format: Article
Language:English
Subjects:
Ablation
Antiarrhythmics
Arrhythmia (R Kabra
Cardiac arrhythmia
Cardiology
Catheters
Drug therapy
Heart failure
Hospitalization
Hypertension
Medicine
Medicine & Public Health
Quality of life
Section Editor
Success
Topical Collection on Arrhythmia
Veins & arteries
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of review Catheter ablation has emerged as the most effective long-term rhythm controlling strategy in patients with symptomatic atrial fibrillation (AF). Over the last few years, the role of ablation has shifted from a last-resort strategy toward a first-line approach in AF management. The purpose of this review is to highlight the rationale behind an early ablation strategy and to summarize recent data regarding its effectiveness. Recent findings Pulmonary vein isolation (PVI), the cornerstone of catheter ablation of AF, is superior to antiarrhythmic drugs (AADs) in preventing recurrence of AF. PVI is most effective when performed early in the disease process. Recent studies have shown significant long-term benefit in patients treated with PVI early after AF diagnosis and/or prior to use of AADs. Summary PVI is emerging as a highly appropriate first-line therapy for patients with symptomatic AF. As ablation technologies continue to improve, offering PVI to patients with recently diagnosed atrial fibrillation may become standard of care.
ISSN:1092-8464
1534-3189
DOI:10.1007/s11936-020-00840-y